Advocacy intelligence hub — real-time data for patient organizations
Cairo University — NA
Weill Medical College of Cornell University — PHASE2
University Hospital, Toulouse — PHASE2
SHINKEI Therapeutics, Inc — PHASE2
University of Pennsylvania — PHASE2
Consorci Sanitari de Terrassa
Consorci Sanitari de Terrassa
Azienda Sanitaria dell'Alto Adige — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
HepaGam B
(hepatitis B immune globulin (human))Orphan drugstandardCangene Corporation
Human Immunoglobulin [EPC]
Amie Hiller, MD, M.D
Oregon Health and Science University
📍 PORTLAND, OR
Viviana Versace, RPT
hospital of Vipiteno
📍 MIAMI, FL
Eun Kyoung Lee
Chungnam National University Sejong Hospital
Sooyoung Kim, DMD
Chungnam National University Hospital
📍 MOUNTAIN VIEW, CA
Eunhee Sohn
Chungnam National University Hospital
Anna Puigdellívol-Sánchez, Ph D
Consorci Sanitari de Terrassa